Search research articles
Contact Us
Filters
Showing results (31-40 of 134) with videos related to
Page
of 14
Sort By:
International Journal of Cancer
|
December 13, 2007
Histone deacetylase inhibitor Helminthosporium carbonum (HC)-toxin suppresses the malignant phenotype of neuroblastoma cells
Hedwig E Deubzer, Volker Ehemann, Frank Westermann, et al.
Oncogene
|
December 14, 2004
Altered expression of cell cycle genes distinguishes aggressive neuroblastoma
Alexei L Krasnoselsky, Craig C Whiteford, Jun S Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2008
Subclassification and individual survival time prediction from gene expression data of neuroblastoma patients by using CASPAR
André Oberthuer, Lars Kaderali, Yvonne Kahlert, et al.
Cancer Letters
|
June 6, 2009
Regulation of BIRC5 and its isoform BIRC5-2B in neuroblastoma
Isabella Eckerle, Daniel Muth, Julia Batzler, et al.
Cancer Research
|
March 17, 2011
Cep63 recruits Cdk1 to the centrosome: implications for regulation of mitotic entry, centrosome amplification, and genome maintenance
Harald Löffler, Anne Fechter, Marc Matuszewska, et al.
Genes, Chromosomes & Cancer
|
June 29, 2006
Increased WSB1 copy number correlates with its over-expression which associates with increased survival in neuroblastoma
Qing-Rong Chen, Sven Bilke, Jun S Wei, et al.
Cancer Letters
|
February 12, 2008
Anti-neuroblastoma activity of Helminthosporium carbonum (HC)-toxin is superior to that of other differentiating compounds in vitro
Hedwig E Deubzer, Volker Ehemann, Andreas E Kulozik, et al.
Cell Cycle (Georgetown, Tex.)
|
March 7, 2013
CDK4 inhibition restores G(1)-S arrest in MYCN-amplified neuroblastoma cells in the context of doxorubicin-induced DNA damage
Sina Gogolin, Volker Ehemann, Gabriele Becker, et al.
Bioinformatics (Oxford, England)
|
March 26, 2010
PathWave: discovering patterns of differentially regulated enzymes in metabolic pathways
Gunnar Schramm, Stefan Wiesberg, Nicolle Diessl, et al.
Cancer Letters
|
November 28, 2006
Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease
André Oberthuer, Patrick Warnat, Yvonne Kahlert, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 134) with videos related to
Sort By:
Page
of 14
International Journal of Cancer
|
December 13, 2007
Histone deacetylase inhibitor Helminthosporium carbonum (HC)-toxin suppresses the malignant phenotype of neuroblastoma cells
Hedwig E Deubzer, Volker Ehemann, Frank Westermann, et al.
Oncogene
|
December 14, 2004
Altered expression of cell cycle genes distinguishes aggressive neuroblastoma
Alexei L Krasnoselsky, Craig C Whiteford, Jun S Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2008
Subclassification and individual survival time prediction from gene expression data of neuroblastoma patients by using CASPAR
André Oberthuer, Lars Kaderali, Yvonne Kahlert, et al.
Cancer Letters
|
June 6, 2009
Regulation of BIRC5 and its isoform BIRC5-2B in neuroblastoma
Isabella Eckerle, Daniel Muth, Julia Batzler, et al.
Cancer Research
|
March 17, 2011
Cep63 recruits Cdk1 to the centrosome: implications for regulation of mitotic entry, centrosome amplification, and genome maintenance
Harald Löffler, Anne Fechter, Marc Matuszewska, et al.
Genes, Chromosomes & Cancer
|
June 29, 2006
Increased WSB1 copy number correlates with its over-expression which associates with increased survival in neuroblastoma
Qing-Rong Chen, Sven Bilke, Jun S Wei, et al.
Cancer Letters
|
February 12, 2008
Anti-neuroblastoma activity of Helminthosporium carbonum (HC)-toxin is superior to that of other differentiating compounds in vitro
Hedwig E Deubzer, Volker Ehemann, Andreas E Kulozik, et al.
Cell Cycle (Georgetown, Tex.)
|
March 7, 2013
CDK4 inhibition restores G(1)-S arrest in MYCN-amplified neuroblastoma cells in the context of doxorubicin-induced DNA damage
Sina Gogolin, Volker Ehemann, Gabriele Becker, et al.
Bioinformatics (Oxford, England)
|
March 26, 2010
PathWave: discovering patterns of differentially regulated enzymes in metabolic pathways
Gunnar Schramm, Stefan Wiesberg, Nicolle Diessl, et al.
Cancer Letters
|
November 28, 2006
Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease
André Oberthuer, Patrick Warnat, Yvonne Kahlert, et al.
Page
of 14